1,2-distearoyllecithin has been researched along with pentetic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accardo, A; Aloj, L; Aurilio, M; Cicala, C; De Rosa, G; Maione, F; Morelli, G; Morisco, A; Parisi, A; Salsano, G; Tesauro, D | 1 |
1 other study(ies) available for 1,2-distearoyllecithin and pentetic acid
| Article | Year |
|---|---|
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
Topics: Animals; Antineoplastic Agents; Bombesin; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Pentetic Acid; Peptide Fragments; Phosphatidylcholines; Prostatic Neoplasms; Receptors, Bombesin; Surface-Active Agents; Xenograft Model Antitumor Assays | 2012 |